Molina Healthcare (NYSE:MOH) PT Lowered to $375.00

Molina Healthcare (NYSE:MOH) had its price objective reduced by stock analysts at Wells Fargo & Company from $410.00 to $375.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price suggests a potential upside of 9.62% from the stock’s previous close.

Several other equities research analysts have also weighed in on the company. Truist Financial lifted their price target on Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research report on Tuesday, February 20th. Barclays lowered their price objective on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 25th. Cantor Fitzgerald restated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. StockNews.com lowered shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 8th. Finally, Stephens reiterated an “equal weight” rating and issued a $390.00 price target on shares of Molina Healthcare in a research report on Thursday, April 25th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $398.55.

Molina Healthcare Stock Down 0.5 %

MOH opened at $342.10 on Monday. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a market cap of $20.05 billion, a P/E ratio of 18.56, a P/E/G ratio of 0.96 and a beta of 0.47. The business’s 50-day moving average price is $387.99 and its 200-day moving average price is $372.33.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.45 billion. During the same period in the prior year, the business posted $5.81 earnings per share. Molina Healthcare’s revenue for the quarter was up 21.9% on a year-over-year basis. On average, equities analysts expect that Molina Healthcare will post 23.62 EPS for the current year.

Insider Transactions at Molina Healthcare

In related news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at approximately $14,121,423.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,711 shares of company stock valued at $6,472,517. Company insiders own 1.11% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of MOH. AE Wealth Management LLC boosted its holdings in shares of Molina Healthcare by 33.5% in the 3rd quarter. AE Wealth Management LLC now owns 1,159 shares of the company’s stock valued at $380,000 after acquiring an additional 291 shares during the last quarter. Commonwealth Equity Services LLC grew its position in Molina Healthcare by 1.1% during the 3rd quarter. Commonwealth Equity Services LLC now owns 17,879 shares of the company’s stock worth $5,862,000 after purchasing an additional 192 shares during the period. Hendershot Investments Inc. purchased a new position in shares of Molina Healthcare during the 3rd quarter valued at about $3,257,000. SVB Wealth LLC acquired a new position in shares of Molina Healthcare in the 3rd quarter valued at about $204,000. Finally, Xponance Inc. boosted its stake in shares of Molina Healthcare by 19.3% in the third quarter. Xponance Inc. now owns 21,326 shares of the company’s stock worth $6,993,000 after buying an additional 3,456 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.